Platelet function analysis: at the edge of meaning.
作者信息
Oestreich Julie H, Smyth Susan S, Campbell Charles L
出版信息
Thromb Haemost. 2009 Feb;101(2):217-9.
Abstract
摘要
相似文献
1
Platelet function analysis: at the edge of meaning.
Thromb Haemost. 2009 Feb;101(2):217-9.
2
Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation.
Thromb Haemost. 2009 Feb;101(2):333-9.
3
Clopidogrel response: head-to-head comparison of different platelet assays to identify clopidogrel non responder patients after coronary stenting.
Arch Cardiovasc Dis. 2010 Jan;103(1):39-45. doi: 10.1016/j.acvd.2009.11.004. Epub 2010 Jan 25.
4
Impact of P2Y12 inhibition by clopidogrel on cardiovascular mortality in unselected patients treated by percutaneous coronary angioplasty: a prospective registry.
JACC Cardiovasc Interv. 2010 Jun;3(6):648-56. doi: 10.1016/j.jcin.2010.03.003.
5
Post-thienopyridine platelet response, cardiovascular outcomes, and personalized therapy: En attendant Godot.
JACC Cardiovasc Interv. 2010 Jun;3(6):657-9. doi: 10.1016/j.jcin.2010.03.006.
6
The influencing factors for clopidogrel-mediated platelet inhibition are assay-dependent.
Thromb Res. 2011 Oct;128(4):352-7. doi: 10.1016/j.thromres.2011.05.008. Epub 2011 May 28.
7
Clopidogrel 150 mg/day to overcome low responsiveness in patients undergoing elective percutaneous coronary intervention: results from the VASP-02 (Vasodilator-Stimulated Phosphoprotein-02) randomized study.
JACC Cardiovasc Interv. 2008 Dec;1(6):631-8. doi: 10.1016/j.jcin.2008.09.004.
8
The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis.
Thromb Haemost. 2007 Dec;98(6):1329-34.
9
The effect of elinogrel on high platelet reactivity during dual antiplatelet therapy and the relation to CYP2C19*2 genotype: first experience in patients.
J Thromb Haemost. 2010 Jan;8(1):43-53. doi: 10.1111/j.1538-7836.2009.03648.x. Epub 2009 Oct 11.
10
Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel.
J Thromb Haemost. 2010 Mar;8(3):482-8. doi: 10.1111/j.1538-7836.2009.03733.x. Epub 2009 Dec 21.
引用本文的文献
1
P2Y12 Receptor Inhibitors in Acute Coronary Syndromes: What Is New on the Horizon?
Cardiol Res Pract. 2013;2013:195456. doi: 10.1155/2013/195456. Epub 2013 Feb 19.
本文引用的文献
1
Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients.
Eur Heart J. 2008 Dec;29(23):2877-85. doi: 10.1093/eurheartj/ehn419. Epub 2008 Sep 30.
2
Clinical implications of clopidogrel resistance.
Thromb Haemost. 2008 Aug;100(2):196-203.
3
Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease.
Thromb Haemost. 2008 Jul;100(1):76-82. doi: 10.1160/TH08-03-0136.
4
Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study.
J Am Coll Cardiol. 2008 Apr 8;51(14):1404-11. doi: 10.1016/j.jacc.2007.12.044.
5
Prasugrel versus clopidogrel in patients with acute coronary syndromes.
N Engl J Med. 2007 Nov 15;357(20):2001-15. doi: 10.1056/NEJMoa0706482. Epub 2007 Nov 4.
6
Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients.
J Thromb Haemost. 2007 Sep;5(9):1839-47. doi: 10.1111/j.1538-7836.2007.02656.x.
7
Thienopyridines in cardiovascular disease: focus on clopidogrel resistance.
Thromb Haemost. 2007 Mar;97(3):385-93.
8
A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation.
Am Heart J. 2007 Jan;153(1):66.e9-16. doi: 10.1016/j.ahj.2006.10.010.
9
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention).
Circulation. 2006 Feb 21;113(7):e166-286. doi: 10.1161/CIRCULATIONAHA.106.173220.
10
Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.
Circulation. 2004 Jun 29;109(25):3171-5. doi: 10.1161/01.CIR.0000130846.46168.03. Epub 2004 Jun 7.
Zotero 插件